SK bioscience and Sanofi extend partnership to develop next-gen vaccines
SK bioscience and Sanofi, a global healthcare company, extended their partnership to co-develop next-generation pneumococcal conjugate vaccines (PCVs) for both pediatric and adult populations, the bio company said on Monday.